Microdosing has gained widespread attention in recent years. It’s most commonly associated with substances like LSD and psilocybin, but an increasing number of people are now experimenting with ketamine in the same way.
In this article, we’ll explore the potential benefits and risks of microdosing ketamine, and how it compares to higher, psychoactive doses in terms of overall wellbeing.
Understanding Microdosing
In popular culture, microdosing refers to the repeated use of a drug in small doses, for cognitive benefits, such as improved mood, focus and energy. The term was popularised by psychedelic researcher James Fadiman in his 2011 book The Psychedelic Explorer’s Guide, which included a chapter on low-dose psychedelic use. Fadiman proposed a microdosing protocol of using a tenth of a normal dose every 3 days for a period of around 4-6 weeks.
Psychedelics are known to promote neuroplasticity, the brain’s ability to form new neural connections and reorganise existing ones. The theory behind microdosing is that small, repeated doses could produce a gradual accumulation of these neurological benefits over time, without the intensity of a full psychedelic experience. The evidence for this, however, remains thin.
In practice, people microdose for slightly different reasons. Some aim to stay fully sub-perceptual, taking doses small enough that nothing noticeable happens in the moment. Others aim for mild, functional effects that can be felt specifically on the days they dose, such as more alertness or a lighter mood.
Why Are People Microdosing Ketamine?
Psychological Benefits
Ketamine shares some properties with classical psychedelics. While it has a different mechanism of action, it similarly promotes neuroplasticity, and when provided in therapeutic settings, can have long-lasting benefits for patients with mood disorders. As such, people have begun microdosing ketamine to see whether it provides similar benefits.
While there’s very little published on microdosing ketamine, microdosers have reported some of the following effects:
- More easy to change perspective
- More clarity
- Improved mood
- Improvements in anxiety and depression
Overall, the benefits of microdosing tend to be more related to mood and wellbeing, as opposed to cognitive benefits like focus or memory. However, like with classical psychedelics the actual clinical evidence for ketamine microdosing is sparse.
A meta-analysis published in 2016 compared the therapeutic effects of low dose ketamine with very low dose ketamine, based on data from multiple clinical trials. They found that, while very low dose ketamine had some benefits, improvements in mental health were much more significant for the low dose group.
Convenience and Lifestyle
In addition to potential psychological benefits, microdosing is often seen as more convenient than taking full doses. Because the effects are usually non-psychoactive or very mild, people are typically able to continue with their normal daily activities. It can also reduce the need for clinic visits and specialist supervision, which may save both time and money.
However, this convenience comes with important trade-offs. In most jurisdictions, accessing ketamine without a prescription is illegal, meaning many people who microdose it are doing so outside the law. While a small number of clinics do prescribe ketamine for at-home use, such as Joyous, these services are limited and don’t come with the benefits and safety of in-person clinical oversight.
Is Ketamine Microdosing Safer Than a Full Dose?
Side Effects
Ketamine has a well-established side effect profile, including:
- Dissociation or a sense of detachment from reality
- Distorted perceptions of time, space, or the body
- Dizziness or light-headedness
- Nausea or vomiting
- Increased heart rate and blood pressure
- Sedation or fatigue
- Short-term memory and attention difficulties
These effects tend to be more pronounced at higher doses, which is why they are generally less likely with microdosing. However, in a clinical setting, trained healthcare professionals are present to monitor your safety and manage any side effects that arise. Patients are also carefully screened beforehand to ensure the treatment is appropriate and to minimise potential risks.
Tolerance
Ketamine tolerance develops when the brain becomes less responsive to the drug over time, As tolerance builds, the same dose produces weaker effects, which can lead to reduced benefits or the need to increase dosage.
This may be a particular risk with microdosing, as it often involves frequent use (such as daily or several times a week). Even though each dose is small, the regular exposure can gradually lead to tolerance and increased cumulative intake. In turn, this increases the risk of dependence (see below) and side effects.
In contrast, clinical treatments typically use higher doses that are spaced further apart, allowing time between sessions and potentially reducing the likelihood of tolerance developing.
Psychological Dependence
Ketamine has well-documented potential for psychological dependence, meaning people can come to rely on the way for its effects on mood, perception, or emotional state. As a recognised drug of abuse, ketamine can be reinforcing because it produces rapid relief from distress, dissociation and from difficult thoughts.
With microdosing, this risk can become more pronounced as frequent, repeated use can create a habit loop where a person begins to feel they “need” ketamine to cope with everyday emotions or function normally. Because the doses are small, it can feel less risky, but the regularity and build up of tolerance may actually increase the chance of psychological attachment over time.
In contrast, when ketamine is used in clinical settings at therapeutic doses, the risk of dependence is significantly reduced. Treatments are typically administered infrequently, under medical supervision, and embedded within a broader therapeutic framework. This structure helps prevent habitual use and shifts the focus away from immediate symptom relief toward longer-term psychological processing.
Why Structured Ketamine Therapy Is the Smarter Choice
Ketamine is a powerful, controlled substance with real potential for misuse. The same properties that make it an effective mental health treatment, rapid mood shifts, dissociation, and neuroplasticity, also make it vulnerable to abuse when used without structure.
Microdosing or at-home use increases this risk because it involves frequent, unsupervised access, making it easier for patterns of habitual use and psychological dependence to develop. Without in-person monitoring or real-time clinical judgment, there’s also a greater chance of adverse effects going unmanaged, particularly given ketamine’s strong psychoactive profile.
At Emerge, we provide therapeutic doses of ketamine in a safe clinical setting. Our ketamine treatment protocols are based on strong evidence for rapid and meaningful improvements in mental health conditions after just a few sessions. Crucially, these full-dose treatments produce lasting effects, meaning sessions are spaced out over weeks or months rather than taken daily.
If you have been reading about ketamine microdosing and wondering whether it might help you, we encourage you to consider ketamine therapy as a far less risky option. Ketamine therapy has a strong evidence-base for safety and efficacy when it comes to overcoming symptoms of depression, anxiety, post-traumatic stress disorder (PTSD) and more.
Contact our team at Emerge today to find out more.